ResMed
318 hedge funds and large institutions have $3.58B invested in ResMed in 2014 Q1 according to their latest regulatory filings, with 39 funds opening new positions, 108 increasing their positions, 112 reducing their positions, and 45 closing their positions.
4% less repeat investments, than reductions
Existing positions increased: 108 | Existing positions reduced: 112
1.25% less ownership
Funds ownership: 57.88% → 56.63% (-1.3%)
3% less funds holding
Funds holding: 328 → 318 (-10)
6% less capital invested
Capital invested by funds: $3.83B → $3.58B (-$247M)
13% less first-time investments, than exits
New positions opened: 39 | Existing positions closed: 45
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
63% less call options, than puts
Call options by funds: $36.4M | Put options by funds: $98.8M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$119M |
| 2 |
Invesco
Atlanta,
Georgia
|
+$61.6M |
| 3 |
NC
Nicholas Company
Milwaukee,
Wisconsin
|
+$25.5M |
| 4 |
LCG
Luxor Capital Group
New York
|
+$23.8M |
| 5 |
Two Sigma Investments
New York
|
+$16.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
-$101M |
| 2 |
Citigroup
New York
|
-$47.6M |
| 3 |
SGAM
Smith Group Asset Management
Dallas,
Texas
|
-$47.2M |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$37.8M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$36.3M |
RMD Hedge Fund Activity: Q1 2014 in Review
318 of the 3,463 institutional investors tracked by Wall St. Rank reported a position in ResMed (RMD) for Q1 2014, worth a combined $3.58B — down 6.4% from $3.83B a quarter earlier.
Sellers outnumbered buyers: 45 funds closed out of RMD and 39 opened new positions — a net loss of 6 holders — while 112 trimmed existing stakes and 108 added.
The largest buyer was Fidelity Investments, adding an estimated $119M. The largest seller was Capital Research Global Investors, cutting an estimated $101M.
- 318 institutional investors held ResMed (RMD) as of Q1 2014, down from 328 in Q4 2013.
- Funds reported $3.58B of ResMed stock for Q1 2014, down 6.4% quarter-over-quarter.
- 39 funds opened new ResMed positions in Q1 2014 and 45 closed out, a net change of -6 holders.
- The largest ResMed buyer in Q1 2014 was Fidelity Investments, an estimated $119M added.
- The largest ResMed seller in Q1 2014 was Capital Research Global Investors, an estimated $101M sold.
Based on aggregated 13F filings for Q1 2014.